RICHMOND, Va.--(BUSINESS WIRE)--Insmed, Inc. (NASDAQ:INSM) announced today that it will hold a conference call on Thursday, December 7 to discuss the outcome of the trial in the case of Genentech & Tercica v. Insmed. Insmed, the defendant in the patent infringement suit, will discuss the jury verdict which was returned on Wednesday, December 6.
